Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|June 15, 2007
Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitroZeruesenay Desta, Tanja Saussele, Bryan Ward, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2012
In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expressionAnuradha Ramamoorthy, Lang Li, Andrea Gaedigk, et al.
Hormones & Cancer|October 8, 2011
Functional characterization of a genetic polymorphism in the promoter of the ESR2 geneSantosh Philips, Alexandra Richter, Steffi Oesterreich, et al.
The American Journal of Cardiology|February 22, 2005
Effect of cirrhosis and liver transplantation on the gender difference in QT intervalAdegboyega Q Adigun, Amar G Pinto, David A Flockhart, et al.
Pharmacogenetics and Genomics|June 11, 2009
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activityMillion Arefayene, Santosh Philips, Donghua Cao, et al.
Journal of Cardiovascular Pharmacology|September 3, 2011
Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesisMarcelo F Montenegro, Carla S Ceron, Maria C O Salgado, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 5, 2013
Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifenJinzhong Liu, Peter J Flockhart, Deshun Lu, et al.
Bioorganic & Medicinal Chemistry|September 21, 2016
A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and βLi-Ming Zhao, Hai-Shan Jin, Jinzhong Liu, et al.
Pageof 14